Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia: A Systematic Review.

Conclusion: Available evidence about the risk-benefit ratio of antiplatelet therapy in adults with ET is highly uncertain. Primary Funding Source: Regional Medical Associates. (PROSPERO: CRD42015027051). PMID: 28632284 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research